Table 4. Clinical and laboratory characteristics of patients with severe Corynebacterium striatum pneumonia and methicillin-resistant Staphylococcus aureus pneumonia, Seoul, South Korea, 2014–2019*.
| Characteristics | Total, n = 130 | C. striatum, n = 27 | MRSA, n = 103 | p value |
|---|---|---|---|---|
| Clinical manifestation | ||||
| Dyspnea | 106 (81.5) | 25 (92.6) | 81 (78.6) | 0.16 |
| Fever, temperature >38°C | 103 (79.2) | 18 (66.7) | 85 (82.5) | 0.07 |
| Sputum | 92 (70.8) | 16 (59.3) | 76 (73.8) | 0.14 |
| Cough | 57 (43.8) | 11 (40.7) | 46 (44.7) | 0.72 |
| Altered mental status | 46 (35.4) | 10 (37.0) | 36 (35.0) | 0.84 |
| Diarrhea | 4 (3.1) | 2 (7.4) | 2 (1.9) | 0.19 |
| Septic shock at ICU admission | 81 (62.3) | 12 (44.4) | 69 (67.0) | 0.03 |
| Mechanical ventilation | 127 (97.7) | 27 (100) | 100 (97.1) | 1.00 |
| APACHE II score, mean (SD) | 25.6 (8.1) | 26.4 (11.9) | 26.0 (7.0) | 0.72 |
| SOFA score, mean (SD) | 9.5 (3.7) | 9.5 (3.4) | 9.5 (3.7) | 0.99 |
| Bacteremia |
19 (14.6) |
1 (3.7) |
18 (17.5) |
0.12 |
| Laboratory findings, median (IQR) | ||||
| Leukocyte count, cells/mL | 10,950 (7,800–15,625) | 11,600 (4,800–15,900) | 10,700 (8,400–15,600) | 0.26 |
| Platelets, × 103/mL | 159 (81–242) | 123 (55–230) | 171 (102–245) | 0.14 |
| C-reactive protein, mg/dL | 11.3 (5.5–19.3) | 13.6 (8.0–19.8) | 10.8 (5.4–18.6) | 0.61 |
| Procalcitonin, ng/mL | 1.1 (0.3–3.9) | 0.3 (0.1–1.3) | 1.8 (0.4–4.2) | <0.01 |
*Values are no. (%) except as indicated APACHE, acute physiology and chronic health evaluation; BAL, bronchoalveolar lavage; ICU, intensive care unit; IQR, interquartile range; MRSA, methicillin-resistant Staphylococcus aureus; SOFA, sequential organ failure assessment.